Yueling Zhang Selected Research

Hemocyanins

1/2022	LvHemB1, a novel cationic antimicrobial peptide derived from the hemocyanin of Litopenaeus vannamei, induces cancer cell death by targeting mitochondrial voltage-dependent anion channel 1.
1/2019	N-terminal diversity of Litopenaeus vannamei hemocyanin and immunity.
1/2019	Analysis of Litopenaeus vannamei hemocyanin interacting proteins reveals its role in hemolymph clotting.
12/2018	A Litopenaeus vannamei Hemocyanin-Derived Antimicrobial Peptide (Peptide B11) Attenuates Cancer Cells' Proliferation.
1/2018	Trypsin of Litopenaeus vannamei is required for the generation of hemocyanin-derived peptides.
12/2017	Glycosylation of hemocyanin in Litopenaeus vannamei is an antibacterial response feature.
1/2017	Litopenaeus vannamei hemocyanin exhibits antitumor activity in S180 mouse model in vivo.
9/2016	Identification and characterization of an 18.4kDa antimicrobial truncation from shrimp Litopenaeus vannamei hemocyanin upon Vibrio parahaemolyticus infection.
10/2015	Cloning and characterization of a novel hemocyanin variant LvHMCV4 from shrimp Litopenaeus vannamei.
7/2013	Identification of a novel alternative splicing variant of hemocyanin from shrimp Litopenaeus vannamei.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yueling Zhang Research Topics

Disease

28	Infections 01/2022 - 05/2012
10	Neoplasms (Cancer) 01/2022 - 04/2014
9	Inflammation (Inflammations) 01/2022 - 03/2015
4	Virus Diseases (Viral Diseases) 01/2022 - 01/2020
3	Carcinogenesis 01/2022 - 03/2018
3	Bacterial Infections (Bacterial Infection) 03/2020 - 01/2013
3	Porcine Reproductive and Respiratory Syndrome (PRRS) 10/2018 - 05/2012
2	Ischemic Stroke 04/2022 - 01/2022
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2018
2	Foodborne Diseases 12/2020 - 10/2020
2	Hepatocellular Carcinoma (Hepatoma) 12/2018 - 11/2018
1	Multiple Sclerosis 01/2022
1	Embolic Stroke 01/2022
1	Cerebral Hemorrhage 01/2022
1	Down Syndrome (Down's Syndrome) 01/2022
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022
1	Nasopharyngitis 01/2022
1	Glioma (Gliomas) 07/2021
1	Breast Neoplasms (Breast Cancer) 05/2021
1	Melanosis (Freckles) 05/2020
1	Lymphoma (Lymphomas) 01/2020
1	Hematoma 09/2019
1	Stroke (Strokes) 09/2019
1	Alzheimer Disease (Alzheimer's Disease) 08/2019
1	Neuroinflammatory Diseases 08/2019
1	Pleurisy (Pleuritis) 07/2019
1	Pleural Tuberculosis 07/2019

Drug/Important Bio-Agent (IBA)

11	HemocyaninsIBA 01/2022 - 08/2009
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2014
7	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2013
6	LipopolysaccharidesIBA 01/2022 - 01/2018
6	Peptides (Polypeptides)IBA 01/2022 - 05/2012
4	Pattern Recognition ReceptorsIBA 10/2018 - 05/2012
4	Messenger RNA (mRNA)IBA 10/2015 - 05/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
3	Antimicrobial PeptidesIBA 12/2020 - 12/2018
3	Poly I-CIBA 06/2019 - 01/2013
3	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2018 - 05/2012
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2022 - 12/2018
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2020
2	C-Type Lectins (C-Type Lectin)IBA 01/2022 - 04/2019
2	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 11/2017
2	Biological ProductsIBA 01/2021 - 01/2014
2	Food PreservativesIBA 12/2020 - 10/2020
2	Blood Proteins (Serum Proteins)IBA 01/2020 - 01/2019
2	Polysaccharides (Glycans)IBA 01/2020 - 12/2017
2	TrypsinIBA 01/2020 - 01/2018
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2019 - 03/2018
1	complement 1q receptorIBA 01/2022
1	ocrelizumabIBA 01/2022
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2022
1	Voltage-Dependent Anion Channel 1IBA 01/2022
1	UbiquitinIBA 01/2022
1	Antimicrobial Cationic PeptidesIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Laminin ReceptorsIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	ChitinIBA 01/2022
1	IntegrinsIBA 01/2022
1	Cell Adhesion MoleculesIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Ligases (Synthetase)IBA 01/2022
1	Long Noncoding RNAIBA 07/2021
1	gamma-Butyrobetaine DioxygenaseIBA 08/2020
1	potassium transporting ATPaseIBA 08/2020
1	Thiosulfate Sulfurtransferase (Rhodanese)IBA 08/2020
1	TrehaloseIBA 08/2020
1	Choline (Choline Chloride)IBA 08/2020
1	Phospholipase DIBA 08/2020
1	Lysine (L-Lysine)FDA Link 08/2020
1	SphingolipidsIBA 08/2020
1	SodiumIBA 08/2020
1	CathelicidinsIBA 03/2020
1	BMAP-27IBA 03/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 03/2020
1	SirtuinsIBA 03/2020
1	Sterol Regulatory Element Binding ProteinsIBA 01/2020
1	Glycoside Hydrolases (Endoglycosidases)IBA 01/2020
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2020
1	Apoptosis Inducing FactorIBA 01/2020
1	Casein Kinase II (Casein Kinase 2)IBA 11/2019
1	Small Interfering RNA (siRNA)IBA 10/2019
1	Protein Isoforms (Isoforms)IBA 10/2019
1	Viral DNAIBA 10/2019
1	Amyloid (Amyloid Fibrils)IBA 08/2019
1	CytokinesIBA 08/2019
1	Amino Acids FDA Link 04/2019
1	Factor V (Coagulation Factor V)IBA 04/2019
1	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 04/2019
1	Lysosomal Membrane ProteinsIBA 04/2019

Therapy/Procedure

4	Therapeutics 04/2022 - 04/2014
2	Thrombectomy 04/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Aftercare (After-Treatment) 09/2019
1	Central Venous Catheters 07/2019